Old Web
English
Sign In
Acemap
>
authorDetail
>
Thomas Maier
Thomas Maier
Aventis Pharma
Chemistry
Cardiology
Internal medicine
Anesthesia
Medicine
4
Papers
174
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Discovery and Optimization of 1-Phenoxy-2-aminoindanes as Potent, Selective, and Orally Bioavailable Inhibitors of the Na+/H+ Exchanger Type 3 (NHE3)
2016
Journal of Medicinal Chemistry
Nils Rackelmann
Hans Matter
Heinrich Christian Englert
Markus Follmann
Thomas Maier
John Weston
Petra Arndt
Winfried Heyse
Katharina Mertsch
Klaus Wirth
Laurent Bialy
Show All
Source
Cite
Save
Citations (7)
Discovery and pharmacological characterization of a novel potent inhibitor of diacylglycerol‐sensitive TRPC cation channels
2015
British Journal of Pharmacology
Thomas Maier
Markus Follmann
Gerhard Hessler
Kleemann Hw
Hachtel S
Beate Fuchs
Norbert Weissmann
Wolfgang Linz
Tiffany M. Schmidt
Matthias Löhn
Schroeter K
Wang L
Hartmut Rütten
Carsten Strübing
Show All
Source
Cite
Save
Citations (60)
Atrial effects of the novel K+-channel-blocker AVE0118 in anesthetized pigs
2003
Cardiovascular Research
Klaus Wirth
Tobias Paehler
Bjoern Rosenstein
Karsten Knobloch
Thomas Maier
Jennifer Frenzel
Joachim Brendel
Andreas E. Busch
Markus Bleich
Show All
Source
Cite
Save
Citations (82)
NHE1-inhibitor cariporide prevents the transient reperfusion-induced shortening of the monophasic action potential after coronary ischemia in pigs.
2001
Basic Research in Cardiology
Klaus Wirth
Thomas Maier
Andreas E. Busch
Show All
Source
Cite
Save
Citations (25)
1